Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. (SHE:300937)
China flag China · Delayed Price · Currency is CNY
23.80
-0.03 (-0.13%)
At close: Oct 9, 2026

SHE:300937 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
-13.13-12.8513.259.5342.026.4
Depreciation & Amortization
20.9326.8631.5124.3723.8516.57
Other Amortization
12.1910.268.596.123.061.92
Loss (Gain) From Sale of Assets
0.220.010.610.050.080.11
Asset Writedown & Restructuring Costs
0.895.89-0.530.0120.146.46
Loss (Gain) From Sale of Investments
-0.90.361.84-1.544.29-7.52
Provision & Write-off of Bad Debts
11.9110.196.179.89--
Other Operating Activities
14.2415.2519.5219.460.482.15
Change in Accounts Receivable
368.27-5.88-2.48-30.26-18.43-73.83
Change in Inventory
24.34-54.4133.64-117.318.95-133.44
Change in Accounts Payable
-421.532.8523.45-79.4362.628.88
Operating Cash Flow
1.09-13.23124.43-115.47152.67-154.38
Operating Cash Flow Growth
-99.04%-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-8.92-7.57-32.41-35.33-18.32-31.43
Sale of Property, Plant & Equipment
7.897.890.740.540.080.01
Cash Acquisitions
-0.11-00.0720.89-
Divestitures
--1.013.030.33-0.09
Investment in Securities
-153.83-23.39-19.73-7.72-13.68-100.62
Other Investing Activities
41.8644.010.65-95.640.320.19
Investing Cash Flow
-113.1120.94-49.74-135.04-10.39-131.93

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-390.32457.5330.5185.42130.2
Total Debt Issued
430.83390.32457.5330.5185.42130.2
Short-Term Debt Repaid
--434.11-454-195.42-119.2-51
Long-Term Debt Repaid
--6.51-8.42-6.26-5.88-3.79
Lease Payments
-5.81-6.51-8.42-6.26-5.88-3.79
Total Debt Repaid
-313.33-440.61-462.42-201.68-125.08-54.79
Net Debt Issued (Repaid)
117.5-50.3-4.92128.8260.3475.41
Issuance of Common Stock
0.740.740.3---
Common Dividends Paid
-7.07-17.76-30.25-24.12-5.31-20.67
Other Financing Activities
4.29-12.95-2.712.16272.06
Financing Cash Flow
115.46-80.26-34.88107.4257.18326.8

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
0.01-00-0-0-
Net Cash Flow
3.45-72.5539.82-143.1199.4740.49

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
-7.83-20.892.02-150.8134.35-185.81
Free Cash Flow Growth
------
Free Cash Flow Margin
-0.18%-0.47%2.09%-3.40%3.38%-5.46%
Free Cash Flow Per Share
-0.08-0.221.19-1.571.41-2.03
Levered Free Cash Flow
142.16150.718.19-195.93177.55-201.21
Unlevered Free Cash Flow
147.27156.3824.26-191.82181.57-200.07
Free Cash Flow After Leases
-13.64-27.383.6-157.06128.46-189.6

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
82.1483.7259.0265.3644.3830.78
Change in Working Capital
-45.27-69.243.52-233.3758.74-180.48